Cardiology

Muthiah Vaduganathan, MD, MPH, discusses how research of the add-on drug class will continue to evolve into 2021.

What's known about at-risk cardiometabolic patient care during the pandemic.

Drug-induced sudden cardiac death is linked to several medications currently used to treat COVID-19.

A new review from investigators at Columbia University details topics from common comorbidities to potential treatments.

New data from ACC.20/WCC indicates low birth weight in infants could indicate mothers who are at increased risk of heart failure later in life.

How will heart valve options refine and progress over the coming year?

A discussion with a Brigham and Women's Hospital cardiologist on the research of the add-on cardiometabolic drug class.

The document, which includes 11 clinical competencies for NPs and PAs, is the first of its kind from the American College of Cardiology.

How coronavirus spread has affected a New York institution's invasive cardiology department.

New research presented at ACC.20/WCC suggests increased protein intake could reduce the risk of atrial fibrillation in older women up to 8%.

The author of the first systematic evaluation of commissural alignment in TAVR shares his team's findings.

Data published in NEJM demonstrate the siRNA agent's ability to lower cholesterol in patients with multiple conditions.

In the face of the worldwide coronavirus (COVID-19) pandemic, 4 of the largest cardiology organizations are advising patients receiving treatment with ACE inhibitors (ACE-i) and angiotensin receptor blockers (ARBs) they should not be discontinuing treatment unless it is recommended by their physician.

About 1 in every 20 adult Americans now reguarly uses vaping and e-cigarette products.

Manesh Patel, MD, of Duke University School of Medicine, discusses what we know about COVID-19 and its impact on cardiovascular health.

New research from ACC.20/WCC suggests taking statins before initiating chemotherapy with anthracycline or trastuzumab could reduce treatment-associated cardiotoxicity.

Telehealth tools can identify someone whose symptoms are worsening and connect them to a medical professional.

The Professor of Medicine at Duke University School of Medicine discusses prescribing DOACs and his opinion on a recent meta-analysis in the Annals of Internal Medicine.

Until a few weeks ago, telemedicine was primarily seen as a means to improve access to specialty care, reduce healthcare costs and boost patient engagement. And while it has certainly gained traction over the last several years, it still accounted for an extremely small number of total patient encounters, was largely seen as adjunct to traditional in-person clinical care, and restrictions by payers made reimbursements difficult. Combined, these factors largely curtailed the widespread adoption of the virtual practice model. And then came the Coronavirus. 

New data from ACC.20/WCC is revealing more about the risk of AF associated with various cancer types.

For patients in need of surgery, theres one more way the Coronavirus pandemic may affect them -a shortage of blood.

In an effort to make it easier for physicians and healthcare providers to keep their thumb on the pulse of the COVID-19 pandemic, we’ve created a list of essential websites that can help you monitor the news, stay informed, and assist you in making the best decisions to keep your patients, staff and the community safe.https://edhub.ama-assn.org/jn-learning/video-player/18315311

In a show of solidarity, the major cardiology organizations have released statements addressing the topic.

A new meta-analysis found dual therapy was associated with less bleeding events than triple therapy in AF patients after PCI.

New research suggests taking low-dose aspirin could reduce the risk of hepatocellular carcinoma in high-risk patients.